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ABSTRACT 
Congenital heart disease (CHD) results in 
neonatal morbidity and mortality. Prenatal 
diagnosis allows preparing an appropriate 
perinatal and postnatal care. Babies born 
in low-risk level sites with unexpected 
CHD may have poorer outcomes. The pur-
pose of this study was to compare results 
of foetal echocardiography to postnatal 
findings and assess the impact of antenatal 
suspicions of CHD on postnatal manage-
ment. Medical records of mother-infant 
pairs with CHD admitted to the Neonatal 
Intensive Care Unit (NICU) of the Medi-
cal University of Gdansk from 01.01.  to 
31.12.2013 were reviewed. We analysed if 
the defect was detected pre- or postnatally, 
and if the diagnosis was made by the ob-
stetrician from low-risk level sites (level I) 
or from a tertiary care centre (level II so-
nography). The overall incidence of CHD 
was 68 (3,4%). Critical congenital heart de-
fects (CCHD) were found in 24 neonates 
(1,2%), 21 were diagnosed prenatally, 3 
were transferred from 1st level units. 
Correlation between prenatal diagnosis 
made at our centre and postnatal findings 
was achieved in 47,7%. Accuracy in all 
prenatal and postnatal findings for both I 
and II sonography levels was 35,2%. There 
were major differences in the dispropor-
tion of the great vessels and postnatal 
confirmation of coarctation of the aorta 
(CoAo) (7,1%). We obtained a high ac-
curacy of prenatal and postnatal findings 
in detection of lesions such as Tetralogy of 
Fallot (ToF), transposition of the great ar-
teries (TGA), DORV (double outlet right 
ventricle) and Critical Pulmonary Steno-
sis, which require an outflow tract view 
(92,9% of cases). Conclusions: We con-
firmed increasing diagnostic rates when 
the diagnostics is performed at a tertiary 
care centre. These results are in agreement 
with literature stating that prenatal detec-
tion of CoAo is still challenging. 
Despite the high rates of misdiagnosis, ma-
jority of infants benefited from prenatally 
diagnosed CCHD. 
Key words: critical congenital heart disease, 
foetal, neonatal echocardiography, prenatal 
diagnosis.
INTRODUCTION 
Congenital heart disease (CHD) results in 
significant neonatal morbidity and mortal-
ity. (1,2)
Prenatal diagnosis of CHD is increasingly 
common; it varies from 16 to 65% depend-
ing on the experience of the centre and 
that of the physician. (3) Previous studies 
have shown big disparities in detection rate 
between university centres and peripheral 
practices. Many countries attempted to 
introduce guidelines for foetal screening 
cardiac examination. Using a four cham-
ber view is advocated for obstetric scan. 
But some lesions are not evident from 
this scanning plan. Without using the ex-
tended scan like three vessel view, some 
of severe CHD, such as coarctation of the 
aorta (CoAo) remains undetected before 
birth. (4-6) Prenatal diagnosis allows to re-
fer the parents to tertiary medical centres 
and prepare for planned delivery, as well 
as establish an appropriate perinatal and 
postnatal therapeutic plan. (7-9) 
Duct dependent heart disease used to be 
considered as critical CHD (CCHD) in 
paediatric cardiology. In case of defects 
diagnosed after birth, after ductus arte-
riosus (DA) is closed, the infant that did 
not receive prostaglandin (PGE) was in a 
life-threatening situation. (10) When the 
defect is detected prenatally and the infant 
is given PGE as planned, the prognosis for 
good outcomes of the treatment becomes 
remarkably better. (8,11,12) Prenatal as-
sessment of severity of a cardiac disease 
seems to be the most important. On ac-
count of that, it can be planned whether 
the infant may require immediate inter-
vention in the first hours after birth or can 
be stabilized with a PGE infusion and may 
not require a surgery in the first hours of 
life. (8,11,12) Researches have recently ap-
proached  to creating a classification of the 
management of foetuses in the delivery 
room, based on the prenatal diagnosis and 
the expected diagnosis at birth.
In Poland, Responek and Słodki defined 
four groups of CHD: the severest heart 
defects, severe urgent heart defects, severe 
planned heart defects and planned heart 
defects. (11) Berkley et al. proposed 5 care 
plans, depending on the expected severity 
of CHD, starting from comfort care in case 
of lethal defects up to a delivery at a ter-
tiary centre with planned delayed surgery 
at a tertiary cardiac centre or maternal 
transport with delivery at a tertiary cardiac 
centre. 
In case when the prenatally expected se-
verity of a defect and the suggested peri-
natal care plan are corresponding to the af-
ter-birth diagnosis, even if there are some 
differences in the anatomy of the defect, 
they can be classified as minor variations 
in prenatal and postnatal diagnosis. When 
the previously planned care program needs 
to be modified, it has to be classified as ma-
jor variation. (12) Babies born in low-risk 
level sites with unexpected CHD may have 
significantly poorer outcomes due to lack 
of immediate access to appropriate special-
ity care. (13) 
Prenatal suspicion of CHD, even if it turns 
out false positive, always instigates paren-
tal anxiety and requires detailed paediatric 
cardiac evaluation.
The purpose of this study was to compare 
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results of foetal echocardiography (FE-
CHO) to postnatal findings and to assess 
the impact of antenatal suspicions of CHD 
on postnatal management.
METHODS 
Medical records of mother-infant pairs 
with CHD or other cardiac disorders ad-
mitted to the Neonatal Intensive Care 
Unit (NICU) of the Medical University of 
Gdansk from 01.01. to 31.12.2013 were re-
viewed.  
We analysed if the defect was detected pre- 
or postnatally, and if the diagnosis was 
made by the obstetrician from low-risk 
level sites (level I) or from a tertiary care 
centre (level II sonography). 
Foetuses referred to our tertiary perinatal 
care centre had been scanned by a perina-
tologist specialized in foetal medicine. 
The types of CHD recognized prenatally 
were divided into groups based on the 
echocardiographic views required to iden-
tify the disease in the foetus. Group 1 were 
those malformations identified by a four-
chamber view alone. Group 2 were those 
identified by the addition of an outflow 
tracts view. Group 3 were those defects 
which needed other views (table 1).
Disproportion of the great vessels was de-
scribed separately. There were 28 prenatal 
suspicions of these anomalies. 
Additionally, a separate group of others 
findings, like: cardiomegaly – 2, dextrocar-
dia – 1, normal echo – 2, was isolated. 
Postnatal confirmation was obtained on 
the basis of neonatal echocardiography 
(NECHO), performed by paediatric car-
diologist before discharging the infants 
home or transferring to surgery centre. 
Late outcomes were obtained by review-
ing medical records of paediatrics cardiac 
centre. 
We compared the results of foetal and neo-
natal echocardiograms. Based on Berkley’s 
suggestions, we classified differences as 
minor or major variations. A minor vari-
ation was the one that did not result in a 
treatment plan change, while a major vari-
ation did result in a treatment plan change. 
We looked at the accuracy of the prenatal 
and postnatal diagnosis in regards to guid-
ing neonatal management after delivery. 
Arrhythmias without structural heart dis-
ease were excluded from the study.
STATISTICAL ANALYSIS 
Accuracy of prenatal and postnatal diag-
nosis was evaluated by chi-square distri-
bution and independence tests, using IBM 
SPSS 23.  
RESULTS 
The amount of cardiac disorders in neo-
nates hospitalized in our facility (2008 in-
fants) over the study period was 74 (3,7%). 
Of them 68 were CHD (3,4% of the whole 
group), in 6 newborns other cardiac disor-
ders were detected (cardiac tumor in 1 in-
fant, dextrocardia – 1 infant, false chordae 
tendineae – 1 and tricuspid insufficiency in 
3 neonates). Severe and critical congenital 
heart defects were found in 24 neonates 
(1,2% of the series, 35,3% of all CHD), 21 
were diagnosed prenatally at our centre, 
3 were transferred from level I units. All 
infants with antenatal suspicion of cardiac 
lesions were admitted to the NICU and ob-
tained cardiac assessment. 
There were 88 foetuses in which an obstet-
ric scan suggested cardiac lesions.
Of them 65 were verified at our centre.  Re-
maining 23 were examined only at level I 
sonography. 
Neonatal findings were similar with prena-
tal diagnosis in 31 cases; all of them were 
recognized at level II facility. There were 29 
of CHD recognized. Minor variations were 
detected in 6 cases, all described as accu-
rate. Additionally, CHD were excluded in 
2 cases referred from level I facilities for 
foetal ECHO; NECHO revealed normal 
heart anatomy and they were assessed as 
accurate. Correlation between prenatal 
diagnosis made at level II sonography and 
postnatal findings was achieved in 47,7% 
of cases. Accuracy in all prenatal and post-
natal findings for both I and II sonography 
levels was achieved in 35,2% of cases (table 
2). 
Accuracy of prenatal and postnatal diag-
nosis was 92,9% (13 cases from 14 foetus-
es) for heart defects requiring outflow view 
for detection, and 30,4% (7 cases from 23 
assessed foetuses) for those presented in 
four chamber view, as well as requiring 
other views for recognition - 33,3% (6 cas-
es among 18 foetuses). Regarding other di-
agnosis represented by 5 cases, there were 
3 corrected ones (60%) (tables 3.1-3.4). 
There were major differences in the dispro-
portion of the great vessels and postnatal 
confirmation of CoAo; from 28 foetuses 
cardiac defects like Aortic Stenosis (AS) 
and CoAo were confirmed postnatally in 
only 2 cases (7,1%) (table 3.5).
There were groups of 21 critical and seri-
ous CHD detected prenatally, defined on 
the basis of a baby’s after-birth condition, 
survival and timing of a surgical inter-
vention: the severest (CHD impossible to 
treat), severe urgent cardiac disease (CHD 
needing invasive procedures within the 
first hours after birth), planned cardiac 
disease (CHD needing invasive proce-
dures within the first months after birth) 
and planned heart defects (which do not 
require cardiac surgery within the first 
months after birth) (table 4). In one case 
a lethal cardiac defect was detected prena-
tally; the neonate’s status deteriorated rap-
idly after birth, the baby received comfort 
care, yet died 2 hours after delivery. Nine-
teen neonates were admitted to urgent or 
planned surgery. There was hypoplastic left 
heart syndrome (HLHS) with intact atrial 
septum (IAS) diagnosed prenatally in 1 
case with a satisfying atrial flow after birth, 
thus previously planned care program 
needed to be modified and the classifica-
tion of a defect changed from severe urgent 
to severe planned (major variation). How-
ever, the infant required prostaglandin and 
a planned surgical intervention. The infant 
with Ebstein’s anomaly and pulmonary 
atresia suspected prenatally as criss-cross 
heart despite of having major variation be-
tween foetal and neonatal ECHO benefited 
from prenatal suspicion of CCHD, because 
the prostaglandin intake has started im-
mediately after birth. The neonate with 
corrected transposition of the great arter-
ies (cTGA) plus ventricular inversion and 
atrio-ventricular block Wenckebach’s type 
required antiarrhythmic treatment but did 
not require a surgery. 
In cases of CCHD, prenatal diagnosis cor-
responded with postnatal findings in 19 of 
21 foetuses diagnosed in our centre (accu-
racy 90,5%) (table 4). 
In the following prenatal examinations, 14 
infants (13 of them examined at our cen-
tre) were diagnosed with cardiac disease 
with no instability expected including: 
mild pulmonary stenosis (PS) (1 baby); 
dextrocardia and Ventricular Septal De-
fect (VSD) (1 baby); dextrocardia (1 baby); 
VSD (3 babies); secundum atrial septal de-
fect (ASD2) (1 baby); cardiac tumor with-
out outflow obstruction (1 baby); tricuspid 
valve regurgitation (TVR) without other 
cardiac malformation (3 babies), dilated 
coronary sinus (1 baby) or bicuspid aortic 
valve (BAV) (1 baby). 
In one neonate referred from level I facil-
ity for delivery at our centre clinically non-
significant CHD (ASD2) occurred. 
In 39 neonates cardiac defects were diag-
nosed after birth in neonatal echocardi-
ography done for other reasons. Defects 
diagnosed postnatally are shown in table 5.
Three neonates without antenatal diagno-
sis of CCHD were referred to our centre 
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Table 1. Division of congenital heart disease (CHD) into groups according to echocardiographic view required for prenatal diagnosis. 
Four-chamber view Outflow tracts view Other view 
Type of CHD No of cases Type of CHD No of cases Type of CHD No of cases
SV 1 AS, VSD, disproportion of the 
great vessels 
1 criss-cross heart, right sided aortic 
arch, PS, VSD
1
ASD2 2 BAV 2 IAA type A, VSD 1
AVSD 3 c-TGA 1 PLSVC 1
HLHS 2 d-TGA, ASD, VSD 1 PLSVC, CoAo, dextrocardia 1
VSD 14 Taussig-Bing syndrome, VSD 
subpulmonic
1 Critical PS, underdevelopment 
of RV
1
cardiac tumor 1 ToF 5 interrupted inferior vena cava 1
Critical PS 1 tricuspid valve regurgitation 12
Mild PS 1
PA, AVSD 1
TOTAL 23 14 18
AS, Aortic stenosis; ASD2, secundum atrial septal defect; AVSD, atrioventricular septal defect; BAV, bicuspid aortic valve; CoAo, coarc-
tation of the Aorta; c-TGA, corrected-TGA; DA, ductus arteriosus; DORV, double outlet right ventricle; d-TGA, dextro-transposition of 
the great arteries; HAA, hypoplastic aortic arch; HD, heart defect; HLHS, hypoplastic left heart syndrome; IAA, interrupted aortic arch; 
IAS, intact atrial septum; IVS, intact ventricle septum; l-TGA, levo-TGA; LVOTO, left venticular outflow tract obstruction; PAPVR, 
partial anomalous pulmonary venous return; PFO, patent foramen ovale; PA, pulmonary atresia; PS, pulmonary stenosis; PLSVC, per-
sistent left superior vena cava; RV, Right Ventricle; ToF, tetralogy of Fallot; tAVC, transitional atrioventricular canal; VSD ventricular 
septal defect.
Table 2. Accuracy of foetal and neonatal echocardiography findings 
Sonography level II 
n=65
Sonography level I 
n=23
Sonography level























No cardiac defects 
n=28
No cardiac defects 
n=22
CHD, congenital heart disease.
Tables 3.1-3.5. Accuracy of foetal echocardiography diagnosis (FECHO) and neonatal echocardiography diagnosis (NECHO) according to 
the echocardiographic view required for prenatal diagnosis. 
Table 3.1. Four chamber view
No
of cases







1 HLHS, intact IAS II HLHS, ASD2, DA - Inaccurate Major 
1 HLHS, Turner 
Syndrome
II HLHS, ASD, DA Accurate - -
1 AS, single ventricle, 
single atrium
II AS, single ventricle, 
single atrium
Accurate - -
1 AVSD, abnormal 
karyotype
II VSD, Abnormal 
karyotype 
Accurate - Minor  
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2 AVSD, abnormal 
karyotype
II  2 x AVSD, abnor-
mal karyotype
2 x Accurate - -
4 VSD II 4 x Normal echo - 4 x Inaccurate
1 VSD, abnormal 
karyotype




2 ASD2 II 2 x Normal ECHO - 2 x Inaccurate -
1 Cardiac tumor II Cardiac tumor Accurate - -







AS, Aortic stenosis; ASD2, secundum atrial septal defect; AVSD, atrioventricular septal defect; BAV, bicuspid aortic valve; CoAo, coarc-
tation of the Aorta; c-TGA, corrected-TGA; DA, ductus arteriosus; DORV, double outlet right ventricle; d-TGA, dextro-transposition of 
the great arteries; HAA, hypoplastic aortic arch; HD, heart defect; HLHS, hypoplastic left heart syndrome; IAA, interrupted aortic arch; 
IAS, intact atrial septum; IVS, intact ventricle septum; l-TGA, levo-TGA; LVOTO, left venticular outflow tract obstruction; PAPVR, 
partial anomalous pulmonary venous return; PFO, patent foramen ovale; PA, pulmonary atresia; PS, pulmonary stenosis; PLSVC, per-
sistent left superior vena cava; RV, Right Ventricle; ToF, tetralogy of Fallot; tAVC, transitional atrioventricular canal; VSD ventricular 
septal defect.
Table 3.2. Outflow view









1 AS, VSD, Disproportion of 
the great vessels
II AS, LVOTO, VSD,  arrhythmia, 
HF
Accurate - Minor 
1 ToF II DORV, VSD, tAVC, DA, PLSVC Accurate - Minor 
1 ToF, right-sided aortic arch II ToF, mild PS, right-sided aortic 
arch
Accurate - -
3 ToF, hypoplastic pulmo-
nary artery
II 3 x ToF, hypoplastic pulmonary 
artery
3 x Accurate - -
1 AVSD, PA II AVSD, PA, DORV Accurate - Minor 
1 Taussig-Bing Syndrome, 
VSD subpulmonic, ar-
rhythmia
II ToF with critical PS
mesocardia
Accurate - Minor 
1 d-TGA, ASD, VSD II d-TGA, PFO, DA Accurate - Minor 
1 c-TGA, arrhythmia II c-TGA, ventricular inversion, 
intact IVS,
L-TGA, AVB 2 degree
Accurate - -
1 Critical PS II Critical PS Accurate - -
1 Mild PS II Mild PS Accurate - -
1 Bicuspid Aortic Valve 
(BAV)
II  BAV Accurate - -
1 Bicuspid Aortic Valve 
(BAV)







AS, Aortic stenosis; ASD2, secundum atrial septal defect; AVSD, atrioventricular septal defect; BAV, bicuspid aortic valve; CoAo, coarc-
tation of the Aorta; c-TGA, corrected-TGA; DA, ductus arteriosus; DORV, double outlet right ventricle; d-TGA, dextro-transposition of 
the great arteries; HAA, hypoplastic aortic arch; HD, heart defect; HLHS, hypoplastic left heart syndrome; IAA, interrupted aortic arch; 
IAS, intact atrial septum; IVS, intact ventricle septum; l-TGA, levo-TGA; LVOTO, left venticular outflow tract obstruction; PAPVR, 
       SIGNA VITAE    |    55
partial anomalous pulmonary venous return; PFO, patent foramen ovale; PA, pulmonary atresia; PS, pulmonary stenosis; PLSVC, per-
sistent left superior vena cava; RV, Right Ventricle; ToF, tetralogy of Fallot; tAVC, transitional atrioventricular canal; VSD ventricular 
septal defect.
Table 3.3. Other view 







1 Criss-cross heart, right-sided 
aortic arch, PS, VSD, 
HF, arrhythmia
II c-TGA, PA, VSD, dextrocardia 
with ventricular inversion, 
Ebstein’s anomaly, arrhythmia, 
HF
- Inaccurate Major 
1 IAA (type A), VSD II IAA (type B), VSD, PAPVR Accurate - -
1 Critical PS, 
underdevelopment of RV
II  Critical PS, 
Right Ventricle Hypoplasia, 
PFO
Accurate - -
1 PLSVC II Dilated coronary sinus-PLSVCAccurate - -
1 PLSVC, CoAo, Dextrocardia, 
SUA
II Dextrocardia, VSD, SUA - Inaccurate Major 
1 Interrupted inferior vena 
cava
II  1 x Normal echo - Inaccurate
1 Tricuspid Valve Regurgita-
tion
 HF, ascites 
II  Tricuspid Valve Regurgitation 
PFO, DA, no HF
Accurate - -
2 Tricuspid Valve Regurgita-
tion
II  2 x Tricuspid Valve Regurgita-
tion
 2 x Accurate
1 Tricuspid Valve Regurgita-
tion
II 1x normal ECHO        - Inaccurate
8 Tricuspid Valve Regurgita-
tion
I  8 x normal ECHO
-






AS, Aortic stenosis; ASD2, secundum atrial septal defect; AVSD, atrioventricular septal defect; BAV, bicuspid aortic valve; CoAo, coarc-
tation of the Aorta; c-TGA, corrected-TGA; DA, ductus arteriosus; DORV, double outlet right ventricle; d-TGA, dextro-transposition of 
the great arteries; HAA, hypoplastic aortic arch; HD, heart defect; HLHS, hypoplastic left heart syndrome; IAA, interrupted aortic arch; 
IAS, intact atrial septum; IVS, intact ventricle septum; l-TGA, levo-TGA; LVOTO, left venticular outflow tract obstruction; PAPVR, 
partial anomalous pulmonary venous return; PFO, patent foramen ovale; PA, pulmonary atresia; PS, pulmonary stenosis; PLSVC, per-
sistent left superior vena cava; RV, Right Ventricle; ToF, tetralogy of Fallot; tAVC, transitional atrioventricular canal; VSD ventricular 
septal defect.
Table 3.4. Other diagnoses






1 Dextrocardia  II Dextrocardia Accurate -
2 Excluded CHD- 2 x 
normal FECHO
 II 2 x Normal ECHO 2 x Accurate -







CHD, congenital heart disease.
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Table 3.5. Disproportion of the great vessels 






1 Disproportion of the 
great vessels
II CoAo, HAA, DORV, 
VSD, DA, BAV
Accurate -
1 Disproportion of the 
great vessels
II CoAo, HAA, DA Accurate -
2 Disproportion of the 
great vessels
II 1xVSD, PFO, DA
1xASD2, DA, enlarge-
ment RV
- 2 x Inaccurate
21 Disproportion of the 
great vessels
II 21 x normal ECHO - 21 x Inaccurate
2 Disproportion of the 
great vessels
I 2 x normal ECHO - 2 x Inaccurate
1 Disproportion of the 
great vessels







AS, Aortic stenosis; ASD2, secundum atrial septal defect; AVSD, atrioventricular septal defect; BAV, bicuspid aortic valve; CoAo, coarc-
tation of the Aorta; c-TGA, corrected-TGA; DA, ductus arteriosus; DORV, double outlet right ventricle; d-TGA, dextro-transposition of 
the great arteries; HAA, hypoplastic aortic arch; HD, heart defect; HLHS, hypoplastic left heart syndrome; IAA, interrupted aortic arch; 
IAS, intact atrial septum; IVS, intact ventricle septum; l-TGA, levo-TGA; LVOTO, left venticular outflow tract obstruction; PAPVR, 
partial anomalous pulmonary venous return; PFO, patent foramen ovale; PA, pulmonary atresia; PS, pulmonary stenosis; PLSVC, per-
sistent left superior vena cava; RV, Right Ventricle; ToF, tetralogy of Fallot; tAVC, transitional atrioventricular canal; VSD ventricular 
septal defect.
Table 4. Critical and Severe Cardiac Defects recognized following prenatal diagnosis (level II sonography)
Severity of 
CHD









Critical PS Accurate Surgery




CoAo, HAA, DA Accurate Surgery 
CoAo, HAA, DORV, VSD, PDA, BAV Accurate Surgery 
IAA (type B), VSD, PAPVR Accurate Surgery 
AS, LVOTO, VSD, Arrhythmia, HF Accurate Surgery 
HLHS, ASD2, DA Accurate Surgery
HLHS, ASD2, DA Major variation Inac-
curate
Surgery 
DORV, VSD, tAVC, DA, PLSVC Accurate Surgery 
AVSD, PA, DORV Accurate Surgery 
ToF with critical PS,  Mesocardia Accurate Surgery, death
3 x ToF, hypoplastic pulmonary artery Accurate 3 x surgery
d-TGA, PFO, PDA Accurate
c-TGA, PA, VSD, dextrocardia with ventricular inversion, 
Ebstein’s anomaly, arrhythmia, HF
Inaccurate Blalock-Taussig shunt, palliative treatment
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from other, non-tertiary units. They were 
diagnosed after delivery with CCHD: 
CoAo with hypoplastic aortic arch with 
ventricular septal defect and ductus ar-
teriosus (CoAo/HAA/VSD/DA); trans-
position of the great arteries (dTGA/DA/
ASD2); and Tetralogy of Fallot (ToF) with 
hypoplastic pulmonary artery).
The neonate with concomitant CoAo and 
HAA was subjected to pulse oximetry test 
3 hours after birth. According to medical 
history, the test yielded negative result. 
The baby remained at well-baby nursery 
for the first 2 days of life, until its status 
deteriorated (pallor, tachypnea, seizures, 
metabolic acidosis and kidney failure oc-
curred). The infant needed to be intu-
bated, required mechanical ventilation 
and a long-term stay at NICU. Despite the 
cardiac treatment, the outcomes were not 
satisfying and resulted in cerebral palsy, 
hydrocephalus and PVL (periventricular 
leukomalacia).
The neonate with dTGA/ASD/DA was 
born in a good general status; however, 
its status deteriorated shortly after birth. 
The baby was intubated and transferred to 
NICU with a suspicion of congenital pneu-
monia or heart defect. The patient was 
transferred immediately to a cardiosurgi-
cal centre; the result of surgical interven-
tion was satisfactory.
The newborn with ToF was transferred to 
our tertiary centre due to respiratory fail-
ure, evidence of heart murmur, dysmor-
phia and central nervous system anomalies 
(agenesis of the corpus callosum) and also 
needed to be intubated and required a long 
stay at NICU. It is not only a heart disease 
that influences his development, but also a 
defect of Central Nervous System (CNS).
DISCUSSION 
Delayed diagnosis of CCHD leads to se-
vere morbidity and mortality as many of 
these undiagnosed newborns become crit-
ically ill with cardiovascular collapse. 
Prenatal diagnosis of CHD by foetal echo-
cardiography is now a firmly established 
Planned 
HD (n=3)
AVSD, abnormal karyotype Accurate Surgery 
AVSD, abnormal karyotype Accurate Surgery, death
ToF, mild PS, right-sided aortic arch Accurate Surgery 
Planned 
HD (n=1)
c-TGA, ventricular inversion, intact IVS, L-TGA, AVB 2 
degree – no surgery






AS, Aortic stenosis; ASD2, secundum atrial septal defect; AVSD, atrioventricular septal defect; BAV, bicuspid aortic valve; CoAo, coarc-
tation of the Aorta; c-TGA, corrected-TGA; DA, ductus arteriosus; DORV, double outlet right ventricle; d-TGA, dextro-transposition 
of the great arteries; HAA, hypoplastic aortic arch; HD, heart defect; HLHS, hypoplastic left heart syndrome; IAA, interrupted aor-
tic arch; IAS, intact atrial septum; IVS, intact ventricle septum; l-TGA, levo-TGA; LVOTO, left venticular outflow tract obstruction; 
PAPVR, partial anomalous pulmonary venous return; PFO, patent foramen ovale; PA, pulmonary atresia; PS, pulmonary stenosis; 
PLSVC, persistent left superior vena cava; RV, Right Ventricle; ToF, tetralogy of Fallot; tAVC, transitional atrioventricular canal; VSD 
ventricular septal defect.
Table 5. Cardiac defects identified postnatally. 







CoAo, HAA, VSD, PDA 1
TGA, PDA, ASD 1
ToF, hypoplastic PA, PFO 1
39
AS, Aortic stenosis; ASD2, secundum atrial septal defect; AVSD, atrioventricular septal defect; BAV, bicuspid aortic valve; CoAo, coarc-
tation of the Aorta; c-TGA, corrected-TGA; DA, ductus arteriosus; DORV, double outlet right ventricle; d-TGA, dextro-transposition 
of the great arteries; HAA, hypoplastic aortic arch; HD, heart defect; HLHS, hypoplastic left heart syndrome; IAA, interrupted aor-
tic arch; IAS, intact atrial septum; IVS, intact ventricle septum; l-TGA, levo-TGA; LVOTO, left venticular outflow tract obstruction; 
PAPVR, partial anomalous pulmonary venous return; PFO, patent foramen ovale; PA, pulmonary atresia; PS, pulmonary stenosis; 
PLSVC, persistent left superior vena cava; RV, Right Ventricle; ToF, tetralogy of Fallot; tAVC, transitional atrioventricular canal; VSD 
ventricular septal defect.
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component of foetal medicine offered in 
many tertiary medical centres. Despite the 
fact, the proportion of CHD detected pre-
natally remains low internationally. (14) 
In many facilities in the United States less 
than 50% of neonates with CHD are diag-
nosed antenatally. (7,15,16)
In Europe, major differences in detection 
rate in various countries were observed. 
The highest detection rates were observed 
in France (48%), Spain (45%) and Germa-
ny (40%), while in Eastern Europe (Croa-
tia, Lithuaniaand Ukraine) the detection 
rate equalled 8%. (14) Mean European 
percentage of detected CHD was calcu-
lated to be 25%. (14) Marek J et al. assessed 
prevalence of CHD based on nationwide 
prenatal ultrasound screening programme 
in Czech Republic at 28,5% in 2003. (17) 
Regarding the diagnoses made at our cen-
tre, overall prenatal detection rate reached 
47,7%. These results placed us in the mid-
dle of mean European detection rate. Some 
previous studies showed similar antenatal 
detection rate. (3,16) Mark K Friedberg 
stated the accuracy of 36% in an academic 
centre. (16) Acherman et al. showed pre-
natal detection rate of 36% for CCHD in 
Southern Nevada, but after developing 
community-wide foetal cardiology pro-
gram, detection rate increased to 71%. 
(5,18) Many other scientific descriptions 
are also stating the increasing percentage 
of prenatal detections, especially at uni-
versity facilities. (12,19-22) So these num-
bers need to be improved. We analysed all 
prenatal suspicions made at any medical 
setting and at any gestational age, so the 
combined accuracy of pre- and postnatal 
findings for both level I and level II sonog-
raphy was 35,2%. Previous studies have 
also noted a higher prenatal detection rate 
made at tertiary-care centres then in low-
level facilities. (19-21) Mark K Friedberg 
indicated 80% of compatibility of diagno-
sis in academic centres versus 23% in other 
practices. (16) It had been described that 
examination of foetus with four cham-
ber view, used as an obstetrical screening 
of CHD, allowed detecting about 40% of 
CHD. (6,23)  In our study, defects requir-
ing four chamber view were identified in 
only 30,4% of cases. We found low detec-
tion rate for septal defects, none of 9 VSD 
suspected in level I sonography centre and 
of 1 suspected in level II centre was proved 
in neonatal echocardiograpy. We observed 
better correlation in recognition of AVSD. 
Our observations are similar to the results 
obtained by Garne et al. evaluating data 
from 20 European registries. (14)
All cases of HLHS found in our study 
were detected prenatally. Of 2 cases of 
suspected HLHS, 2 were proved after de-
livery. Other researchers also stated good 
detection rate of HLHS (four chamber 
abnormality). (16,24) There was a much 
closer correlation observed in our centre 
in detection of lesions such as Tetralogy of 
Fallot, Transposition of the Great Arteries, 
Double Outlet Right Ventricle and Critical 
Pulmonary Stenosis, which require an out-
flow tract view. Contrary to the literature 
that demonstrates low detection rate, we 
obtained a higher accuracy of prenatal and 
postnatal findings in these defects (92,9% 
of cases). Friedberg et al. showed 19% of 
TGA diagnosed prenatally while Allan 
noted detection rate for TGA 3% (outflow 
tract view abnormality). (16,25) 
The results of our study can be explained 
by the fact that all of the described cases 
were examined in level II sonography unit. 
Data from the literature also indicate the 
higher detection rate for defects requiring 
outflow view in academic centres. (16) 
Although some lesions can be accurately 
diagnosed by foetal echocardiography, 
prenatal detection of CoAo is still chal-
lenging. Many authors defined CoAo as 
the most common misdiagnosis. (4,16,26) 
Our observations are consistent with the 
results of other studies. We showed ma-
jor differences in the disproportion of the 
great vessels and postnatal confirmation of 
CoAo (7.1%).
The importance of antenatal detection 
of CCHD cannot be understated. Early 
and accurate prenatal diagnosis allows 
optimizing medical care for mother and 
her child after birth. A multidisciplinary, 
specialized care team including an obste-
trician, a neonatologist and a paediatric 
cardiologist may be useful in improving 
effects and late outcomes of treatment. 
(8,12,22,24,27,28) Arrangement of an ap-
propriate management and delivery plan 
based on foetal echo is even more impor-
tant than the accuracy of pre- and postna-
tal findings. (29) In our work we detected 
3 major variations, including one prenatal 
HLHS with IAS, which classified the find-
ing as the severest cardiac defect. Satisfying 
interatrial communication was discovered 
after birth, classification of the defect was 
modified to severe planned. However, the 
baby benefited from prenatal diagnosis be-
cause s/he was delivered at a tertiary NICU 
where specialized care was taken imme-
diately after birth. This enabled us to start 
an immediate implementation of an ap-
propriate treatment, namely maintenance 
of patent ductus arteriosus by administra-
tion of prostaglandins and planned refer-
ral for surgery prior to development of life-
threatening consequences of the defect. 
Many papers showed that prenatal diag-
nosis of cardiac disease as HLHS, CoAo or 
TGA, reduced early neurologic morbidity 
and improved long-term neurologic out-
comes. (13,30-32) Of 24 CCHD detected 
in our group, 21 were diagnosed on the 
basis of foetal echocardiography. Nineteen 
neonates diagnosed and delivered at our 
centre were referred for planned surgery 
based on foetal and neonatal ECHO find-
ings. Such attitude is associated with better 
long-term outcomes, and, most of all, with 
greater likelihood of normal neurological 
development in these infants. Infants with 
congenital heart disease without prena-
tal diagnosis, born in low-level facilities, 
are at risk of not receiving a needed care 
plan and, in the end, of worse treatment 
outcomes. (12,13,30) Delayed diagnosis in 
patients who survive is the risk of hypoxic/
ischaemic brain injury. Periventricular leu-
komalacia has been reported on MRI im-
aging of the brain in up to 39% of neonates 
with critical CHD. (33) Prenatal diagnosis 
is associated with lower rate of acidosis, less 
frequent neurological complications and 
planned referral for surgery prior to devel-
opment of life-threatening consequences 
of the defect, while a delay in diagnosis 
may lead to hypoxia, shock, multiorgan 
failure and worse outcomes of both early 
and late surgical actions. (13,30,33) These 
can be confirmed by our observations. In-
fant with a CoAo and HAA diagnosed after 
birth was transferred to our unit in shock, 
with acidosis, needed to be intubated and 
required mechanical ventilation. Late out-
comes of the treatment are not satisfying as 
it can result in cerebral palsy and periven-
tricular leukomalacia. 
Notwithstanding the higher prenatal de-
tection rate of CHD done at a tertiary 
setting, foetal cardiac assessment is still 
performed at level I sonography, as preg-
nant women are not referred for foetal 
echo from the primary services. (3,20) 
False positive diagnosis of foetal cardiac 
abnormality results in parents’ anxiety, in 
contrast to misdiagnosis of CCHD in foe-
tus, thereby delaying the diagnosis and, 
consequently, adequate specialized prena-
tal follow-up and delivery management at 
a specialized centre. It should be empha-
sized that infants born at our centre had 
prenatal diagnosis of CCHD, in contrast 
to those born at other sites, which affected 
postnatal management and late outcomes. 
Neonates with CCHD born at non-tertiary 
centres weretransferred to our unit, which 
implies that availability of prenatal diagno-
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sis beyond university clinics is still insuf-
ficient. Newborns with late diagnosis of 
a CCHD were referred to cardiosurgical 
treatment in poor general and neurologi-
cal status, which is another argument for 
identification of an accurate method for 
early detection of critical heart defect.
Conclusions 
The prenatal diagnosis has significant im-
pact on neonatal management, allowing 
appropriate medical care and planning 
surgery immediately after birth. 
We confirmed increasing diagnostic rates 
when the diagnostics is performed at a ter-
tiary care centre. The results of our study 
are in agreement with literature which 
states that prenatal detection of CoAo is 
still challenging. 
Despite the high rates of misdiagnosis, ma-
jority of infants benefited from prenatally 
diagnosed CCHD. Improved accuracy in 
foetal diagnosis can be achieved through 
better organisation of perinatal care.
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